Don't forget that other companies are testing promising vaccines, too. Pfizer may have 1.2b by next year, but AZ and J&J may have vaccines in production, too. J&J's current trial only requires one shot.
Regardless of how you look at this, it's nice to finally get some concrete and positive news.